Home » Topics » Conferences

Conferences
RSS

Allophenylnorstatine HIV protease inhibitors described

July 26, 1996

Gilead Science's sulfone HIV protease inhibitors

July 26, 1996

C85: TxB2 production/phosphoinositide breakdown inhibitor

July 19, 1996

PST-2238: a selective Na+/K+-ATPase inhibitor

July 19, 1996

Potent selective protein farnesyltransferase inhibitor from Pierre Fabre

July 19, 1996

Hybridon's GEM-91 inhibits various steps in HIV-1 replication

July 19, 1996

RWJ-26819: Non-steroidal progestin agonist from R.W. Johnson

July 12, 1996

KGR-1380: A novel glycation inhibitor

July 12, 1996

NEP inhibition research findings

July 12, 1996

WAY-126120: Selective PDE IV inhibitor

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...